Paul Tudor Jones’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $38.3M | Sell |
370,000
-311,806
| -46% | -$27.8M | 0.05% | 260 |
|
|
2026
Q1 | $49M | Buy |
681,806
+513,806
| +306% | +$39.6M | 0.09% | 155 |
|
|
2025
Q4 | $13.3M | Buy |
+168,000
| New | +$13.2M | 0.02% | 575 |
|
|
2025
Q1 | – | Sell |
-977,703
| Closed | -$58.5M | – | 3179 |
|
|
2024
Q4 | $43.9M | Buy |
977,703
+619,958
| +173% | +$34.8M | 0.17% | 46 |
|
|
2024
Q3 | $22.5M | Buy |
357,745
+285,901
| +398% | +$16.7M | 0.08% | 152 |
|
|
2024
Q2 | $4.24M | Buy |
+71,844
| New | +$4.49M | 0.02% | 724 |
|
|
2024
Q1 | – | Sell |
-3,305
| Closed | -$252K | – | 2324 |
|
|
2023
Q4 | $261K | Sell |
3,305
-491,354
| -99% | -$35M | ﹤0.01% | 2095 |
|
|
2023
Q3 | $34.5M | Buy |
494,659
+114,549
| +30% | +$8.12M | 0.35% | 23 |
|
|
2023
Q2 | $26.3M | Sell |
380,110
-79,058
| -17% | -$5.63M | 0.31% | 35 |
|
|
2023
Q1 | $34.1M | Buy |
459,168
+268,042
| +140% | +$22.5M | 0.53% | 5 |
|
|
2022
Q4 | $17.8M | Buy |
191,126
+181,427
| +1,871% | +$17.5M | 0.35% | 19 |
|
|
2022
Q3 | $925K | Sell |
9,699
-62,711
| -87% | -$6.21M | 0.02% | 968 |
|
|
2022
Q2 | $6.71M | Sell |
72,410
-26,521
| -27% | -$2.59M | 0.18% | 112 |
|
|
2022
Q1 | $10M | Buy |
98,931
+57,827
| +141% | +$6.07M | 0.23% | 63 |
|
|
2021
Q4 | $4.24M | Buy |
41,104
+14,159
| +53% | +$1.31M | 0.07% | 318 |
|
|
2021
Q3 | $2.29M | Buy |
+26,945
| New | +$2.26M | 0.04% | 629 |
|
|
2021
Q2 | – | Sell |
-24,013
| Closed | -$1.81M | – | 1653 |
|
|
2021
Q1 | $1.81M | Buy |
24,013
+20,746
| +635% | +$1.51M | 0.04% | 563 |
|
|
2020
Q4 | $223K | Sell |
3,267
-97,603
| -97% | -$6.35M | 0.01% | 1206 |
|
|
2020
Q3 | $5.89M | Buy |
100,870
+66,762
| +196% | +$4.15M | 0.26% | 61 |
|
|
2020
Q2 | $2.22M | Buy |
+34,108
| New | +$2.15M | 0.11% | 218 |
|
|
2020
Q1 | – | Sell |
-33,376
| Closed | -$2.48M | – | 1105 |
|
|
2019
Q4 | $2.48M | Buy |
+33,376
| New | +$2.34M | 0.11% | 210 |
|
|
2019
Q3 | – | Sell |
-80,649
| Closed | -$4.39M | – | 1126 |
|
|
2019
Q2 | $4.39M | Buy |
80,649
+58,264
| +260% | +$3.14M | 0.13% | 116 |
|
|
2019
Q1 | $1.21M | Buy |
+22,385
| New | +$1.38M | 0.05% | 412 |
|
|
2018
Q2 | – | Sell |
-36,809
| Closed | -$2.29M | – | 1073 |
|
|
2018
Q1 | $2.29M | Buy |
36,809
+8,589
| +30% | +$616K | 0.07% | 136 |
|
|
2017
Q4 | $2.05M | Buy |
+28,220
| New | +$2.05M | 0.05% | 167 |
|
|
2017
Q2 | – | Sell |
-59,741
| Closed | -$4.69M | – | 1086 |
|
|
2017
Q1 | $4.69M | Buy |
59,741
+30,796
| +106% | +$2.46M | 0.14% | 104 |
|
|
2016
Q4 | $2.28M | Buy |
28,945
+22,114
| +324% | +$1.79M | 0.06% | 170 |
|
|
2016
Q3 | $608K | Sell |
6,831
-26,336
| -79% | -$2.49M | 0.01% | 633 |
|
|
2016
Q2 | $3.17M | Buy |
+33,167
| New | +$3.31M | 0.07% | 143 |
|
|
2016
Q1 | – | Sell |
-8,633
| Closed | -$839K | – | 1783 |
|
|
2015
Q4 | $844K | Buy |
8,633
+6,033
| +232% | +$591K | 0.02% | 551 |
|
|
2015
Q3 | $251K | Sell |
2,600
-600
| -19% | -$63.1K | 0.01% | 1214 |
|
|
2015
Q2 | $336K | Sell |
3,200
-91,583
| -97% | -$9.36M | 0.01% | 1042 |
|
|
2015
Q1 | $9.78M | Buy |
94,783
+82,936
| +700% | +$8.39M | 0.31% | 51 |
|
|
2014
Q4 | $1.14M | Buy |
+11,847
| New | +$1.04M | 0.04% | 295 |
|
|
2014
Q3 | – | Sell |
-5,542
| Closed | -$418K | – | 1367 |
|
|
2014
Q2 | $418K | Buy |
+5,542
| New | +$419K | 0.02% | 637 |
|
|
2013
Q4 | – | Sell |
-10,500
| Closed | -$596K | – | 1281 |
|
|
2013
Q3 | $596K | Buy |
10,500
+4,200
| +67% | +$250K | 0.02% | 271 |
|
|
2013
Q2 | $360K | Buy |
+6,300
| New | +$365K | 0.03% | 467 |
|
Other funds holding CVS
Paul Tudor Jones's CVS Position: Q2 2026 in Review
Paul Tudor Jones reduced its CVS Health (CVS) stake by 46% in Q2 2026, selling an estimated $27.8M and leaving 370,000 shares worth $38.3M. The position accounts for 0.05% of the portfolio, ranked #260.
Paul Tudor Jones first reported a position in CVS in Q2 2013 and has held it in 37 quarters since. The position peaked at $49M in Q1 2026. 2,059 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Paul Tudor Jones held 370,000 shares of CVS Health worth $38.3M as of Q2 2026.
- Paul Tudor Jones sold 311,806 CVS Health shares in Q2 2026, an estimated $27.8M.
- CVS Health made up 0.05% of Paul Tudor Jones's portfolio in Q2 2026, its #260 holding.
- Paul Tudor Jones first reported a position in CVS Health in Q2 2013 and has held it in 37 quarters since.
- Paul Tudor Jones's CVS Health position peaked at $49M in Q1 2026.
- 2,059 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.